The future of prostate cancer precision medicine: anti-ERG therapies
Sign Up to like & getrecommendations! Published in 2017 at "Translational cancer research"
DOI: 10.21037/15472
Abstract: Prostate cancer (PCa), the most common, non-cutaneous male malignancy (1), is primarily driven by androgen signaling. Thus, clinical management of the disseminated disease is dominated by ever-improving androgen receptor (AR) pathway inhibitors (ARPIs) that have… read more here.
Keywords: medicine; precision medicine; future prostate; prostate cancer ... See more keywords
The future of prostate cancer research: bringing data together, looking back and forward
Sign Up to like & getrecommendations! Published in 2018 at "Translational Andrology and Urology"
DOI: 10.21037/tau.2017.12.32
Abstract: The use of digital data in large data sets will be of pivotal importance to unravel the biological basis of prostate cancer, and to improve on prevention and treatment. For the screening of asymptomatic tumors,… read more here.
Keywords: urology; future prostate; data together; prostate cancer ... See more keywords